Remotely Monitored ICDs Propel Medtronic’s 6% Market Share Gain

Expanding availability and increasing market acceptance of Medtronic's Virtuoso ICD and Concerto cardiac resynchronization therapy product drove a 14% sequential quarterly advance in defibrillator sales, allowing the company to capture market share